Vijay Yabannavar

Nessuna posizione attualmente

63 anni

Health Technology

Finance

Consumer Services

Profilo

Vijay Yabannavar worked as the VP-Process Development & Manufacturing at Emergent Product Development Seattle from 2007 to 2010.
He then held the position of SVP-Manufacturing & Technical Development at Emergent BioSolutions, Inc. After that, he worked as the Chief Manufacturing & Technical Operations Officer at Gritstone bio, Inc. Dr. Yabannavar holds a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from the Indian Institute of Technology Bombay.

Precedenti posizioni note di Vijay Yabannavar

Società	Posizione	Fine
Emergent Product Development Seattle Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA.	Corporate Officer/Principal	01/01/2010
EMERGENT BIOSOLUTIONS INC.	Chief Tech/Sci/R&D Officer	-
GRITSTONE BIO, INC.	Chief Tech/Sci/R&D Officer	-

Vedi nel dettaglio l'esperienza di Vijay Yabannavar

Formazione di Vijay Yabannavar

Massachusetts Institute of Technology	Doctorate Degree
Indian Institute of Technology Bombay	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Vijay Yabannavar

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
EMERGENT BIOSOLUTIONS INC.	Health Technology
GRITSTONE BIO, INC.	Health Technology

Aziende private	1
Emergent Product Development Seattle Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA.	Health Technology